GO
Loading...

Fresenius CEO on APP Deal

Monday, 7 Jul 2008 | 11:10 AM ET

Germany's Fresenius plans to buy America's group APP Pharmaceuticals for $3.7 billion. Ulf Schneider, CEO of Fresenius, spoke to CNBC about the proposed $3.7 billion deal.